Home > M&A deals 2009 > Glaxosmithkline plc acquires Stiefel Laboratories, Inc.
Add-on Acquistion · Life Science · April 2009

Glaxosmithkline plc acquires Stiefel Laboratories, Inc.

On April 20, 2009, Glaxosmithkline plc acquired Stiefel Laboratories, Inc., a life science company in North Carolina, United States, from Blackstone, Inc.

Deal at a glance

AnnouncedApril 20, 2009 TypeAdd-on Acquistion TargetStiefel Laboratories, Inc. Buyer Glaxosmithkline plc Seller Blackstone, Inc. SectorLife Science LocationNorth Carolina, United States ValueMembers only

Target company

Stiefel Laboratories, Inc.
North Carolina, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Company · 84 deals on record
  • 18th transaction in life science
  • 20th transaction in United States
84deals, all time
57in this sector
2022latest

Seller

Private equity firm · 297 deals on record
297investments
6in this sector
128exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Affinivax, Inc.Same lead buyer · May 2022
La Trobe Financial Services Pty Ltd.Same seller · Mar 2022
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Stiefel Laboratories, Inc.?Glaxosmithkline plc acquired Stiefel Laboratories, Inc. on April 20, 2009.

Who sold Stiefel Laboratories, Inc.?Blackstone, Inc. was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2009.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).